<?xml version="1.0" encoding="UTF-8"?>
<table-wrap id="T3" position="float">
 <label>Table 3</label>
 <caption>
  <p>Clinical studies of rosemary and the active constituents on neuropathic pain, stress and anxiety</p>
 </caption>
 <table frame="hsides" rules="groups">
  <thead>
   <tr>
    <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Subjects</th>
    <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Type of extract, constituents/ doses/ Time of exposure</th>
    <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Endpoints </th>
    <th style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Reference</th>
   </tr>
  </thead>
  <tbody>
   <tr>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Rats</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Alcoholic extract; (100, 200, and 400mg/kg); 14 days</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- All three mentioned doses of rosemary extract reduced neuropathic behavioral changes as compared with CCI animals that received the vehicle.
     <break/>- Rosemary extract, 400mg/kg notably declined the levels of Bax, cleaved caspases 3 and 9, Iba1, TNF-Î±, iNOS and TLR4 in comparison with vehicle-treated CCI animals.
    </td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">(
     <xref rid="B84" ref-type="bibr">84</xref>)
    </td>
   </tr>
   <tr>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Mice </td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Rosmanol, cirsimaritin and salvigenin; (50-200 mg/kg)</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- They elicited anxiolytic, antinociceptive, and antidepressant properties.
     <break/>- These compounds were indicated to possess biphasic modulation of GABA
     <sub>A</sub> receptors.
    </td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">(
     <xref rid="B95" ref-type="bibr">95</xref>)
    </td>
   </tr>
   <tr>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Mice</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">essential oil</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- Inhalation of rosemary essential oil considerably minified the immobility time of mice and serum corticosterone level, accompanied by increased brain dopamine level.</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">(
     <xref rid="B121" ref-type="bibr">121</xref>)
    </td>
   </tr>
   <tr>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Mice</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">Rosemary tea; (2% w/w); 4 weeks</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">- Cholinesterase isoforms activity was lowered in the brain of rosemary treated group.</td>
    <td style="background-color:#FFFFFF; color:#000000;" align="left" rowspan="1" colspan="1">(
     <xref rid="B124" ref-type="bibr">124</xref>)
    </td>
   </tr>
  </tbody>
 </table>
</table-wrap>
